These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 15467707

  • 1. Panic induction with cholecystokinin-tetrapeptide (CCK-4) Increases plasma concentrations of the neuroactive steroid 3alpha, 5alpha tetrahydrodeoxycorticosterone (3alpha, 5alpha-THDOC) in healthy volunteers.
    Eser D, di Michele F, Zwanzger P, Pasini A, Baghai TC, Schüle C, Rupprecht R, Romeo E.
    Neuropsychopharmacology; 2005 Jan; 30(1):192-5. PubMed ID: 15467707
    [Abstract] [Full Text] [Related]

  • 2. Changes in CCK-4 induced panic after treatment with the GABA-reuptake inhibitor tiagabine are associated with an increase in 3alpha,5alpha-tetrahydrodeoxycorticosterone concentrations.
    Zwanzger P, Eser D, Romeo E, di Michele F, Baghai TC, Pasini A, Padberg F, Rupprecht R.
    Psychoneuroendocrinology; 2009 Nov; 34(10):1586-9. PubMed ID: 19501468
    [Abstract] [Full Text] [Related]

  • 3. Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: preliminary results.
    Ströhle A, Romeo E, di Michele F, Pasini A, Hermann B, Gajewsky G, Holsboer F, Rupprecht R.
    Arch Gen Psychiatry; 2003 Feb; 60(2):161-8. PubMed ID: 12578433
    [Abstract] [Full Text] [Related]

  • 4. Mirtazapine does not influence tetrahydrodeoxycorticosterone levels in depressed patients.
    Schüle C, Baghai TC, di Michele F, Eser D, Pasini A, Romeo E, Rupprecht R.
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):308-13. PubMed ID: 20218794
    [Abstract] [Full Text] [Related]

  • 5. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder.
    Ströhle A, Holsboer F, Rupprecht R.
    Neuropsychopharmacology; 2000 Mar; 22(3):251-6. PubMed ID: 10693152
    [Abstract] [Full Text] [Related]

  • 6. Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers.
    Zwanzger P, Baghai TC, Schuele C, Ströhle A, Padberg F, Kathmann N, Schwarz M, Möller HJ, Rupprecht R.
    Neuropsychopharmacology; 2001 Nov; 25(5):699-703. PubMed ID: 11682253
    [Abstract] [Full Text] [Related]

  • 7. Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study.
    Zwanzger P, Eser D, Aicher S, Schüle C, Baghai TC, Padberg F, Ella R, Möller HJ, Rupprecht R.
    Neuropsychopharmacology; 2003 May; 28(5):979-84. PubMed ID: 12700707
    [Abstract] [Full Text] [Related]

  • 8. Partial agonism by 3alpha,21-dihydroxy-5beta-pregnan-20-one at the gamma-aminobutyric acidA receptor neurosteroid site.
    Xue BG, Whittemore ER, Park CH, Woodward RM, Lan NC, Gee KW.
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1095-101. PubMed ID: 9190841
    [Abstract] [Full Text] [Related]

  • 9. Changes in neuroactive steroid secretion associated with CO2-induced panic attacks in normal individuals.
    Brambilla F, Perini G, Serra M, Pisu MG, Zanone S, Toffanin T, Milleri S, Garcia CS, Biggio G.
    Psychoneuroendocrinology; 2013 Oct; 38(10):2234-42. PubMed ID: 23702252
    [Abstract] [Full Text] [Related]

  • 10. Differential effects to CCK-4-induced panic by dexamethasone and hydrocortisone.
    Demiralay C, Jahn H, Kellner M, Yassouridis A, Wiedemann K.
    World J Biol Psychiatry; 2012 Oct; 13(7):526-34. PubMed ID: 22111662
    [Abstract] [Full Text] [Related]

  • 11. Megestrol attenuates the hormonal response to CCK-4-induced panic attacks.
    Raedler TJ, Jahn H, Goedeken B, Gescher DM, Kellner M, Wiedemann K.
    Depress Anxiety; 2006 Oct; 23(3):139-44. PubMed ID: 16470820
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of ethanol on serum GABAergic 3alpha,5alpha/3alpha,5beta neuroactive steroids in mice, rats, cynomolgus monkeys, and humans.
    Porcu P, O'Buckley TK, Alward SE, Song SC, Grant KA, de Wit H, Leslie Morrow A.
    Alcohol Clin Exp Res; 2010 Mar 01; 34(3):432-42. PubMed ID: 20028362
    [Abstract] [Full Text] [Related]

  • 13. Preliminary evidence for an association between aggressive and hostile behaviour and 3alpha,5alpha-tetrahydroprogesterone plasma levels in schizophrenia.
    Spalletta G, Romeo E, Bonaviri G, Bernardi G, Caltagirone C, di Michele F.
    J Psychiatry Neurosci; 2005 Jan 01; 30(1):49-52. PubMed ID: 15644998
    [Abstract] [Full Text] [Related]

  • 14. Long-term treatment with clozapine does not affect morning circulating levels of allopregnanolone and THDOC in patients with schizophrenia: a preliminary study.
    Monteleone P, Fabrazzo M, Serra M, Tortorella A, Pisu MG, Biggio G, Maj M.
    J Clin Psychopharmacol; 2004 Aug 01; 24(4):437-40. PubMed ID: 15232336
    [Abstract] [Full Text] [Related]

  • 15. Impact of loudness dependency of auditory evoked potentials on the panic response to CCK-4.
    Eser D, Leicht G, Baghai T, Pogarell O, Schüle C, Karch S, Nothdurfter C, Rupprecht R, Mulert C.
    J Psychiatr Res; 2009 Jan 01; 43(4):393-400. PubMed ID: 18534623
    [Abstract] [Full Text] [Related]

  • 16. GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment.
    Ströhle A, Romeo E, di Michele F, Pasini A, Yassouridis A, Holsboer F, Rupprecht R.
    Am J Psychiatry; 2002 Jan 01; 159(1):145-7. PubMed ID: 11772707
    [Abstract] [Full Text] [Related]

  • 17. Relationship between omega-3 fatty acids and plasma neuroactive steroids in alcoholism, depression and controls.
    Nieminen LR, Makino KK, Mehta N, Virkkunen M, Kim HY, Hibbeln JR.
    Prostaglandins Leukot Essent Fatty Acids; 2006 Jan 01; 75(4-5):309-14. PubMed ID: 16959481
    [Abstract] [Full Text] [Related]

  • 18. Copeptin - A potential endocrine surrogate marker of CCK-4-induced panic symptoms?
    Demiralay C, Agorastos A, Yassouridis A, Jahn H, Wiedemann K, Kellner M.
    Psychoneuroendocrinology; 2017 Feb 01; 76():14-18. PubMed ID: 27871026
    [Abstract] [Full Text] [Related]

  • 19. Neurosteroid secretion in panic disorder.
    Brambilla F, Biggio G, Pisu MG, Bellodi L, Perna G, Bogdanovich-Djukic V, Purdy RH, Serra M.
    Psychiatry Res; 2003 May 30; 118(2):107-16. PubMed ID: 12798975
    [Abstract] [Full Text] [Related]

  • 20. Neuroactive steroids as modulators of depression and anxiety.
    Eser D, Romeo E, Baghai TC, di Michele F, Schüle C, Pasini A, Zwanzger P, Padberg F, Rupprecht R.
    Neuroscience; 2006 May 30; 138(3):1041-8. PubMed ID: 16310959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.